Cytyc expands ob/gyn franchise
This article was originally published in The Gray Sheet
Executive Summary
ThinPrep cervical cytology test manufacturer announces closure of its $325 mil. Novacept acquisition March 24. Cytyc is doubling its OB/Gyn sales force targeting ob/gyn physicians in order to make Novacept's NovaSure the top-selling menorrhagia treatment system (1"The Gray Sheet" March 8, 2004, p. 21)...